Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX21107 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX21107, RRID:AB_368764
- Product name
- CA125 antibody [X75]
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
Submitted references Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Jennings VA, Ilett EJ, Scott KJ, West EJ, Vile R, Pandha H, Harrington K, Young A, Hall GD, Coffey M, Selby P, Errington-Mais F, Melcher AA
International journal of cancer 2014 Mar 1;134(5):1091-101
International journal of cancer 2014 Mar 1;134(5):1091-101
Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP
PloS one 2011;6(9):e22842
PloS one 2011;6(9):e22842
No comments: Submit comment
No validations: Submit validation data